Span Generics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 146.51%
- Profit Growth -45.55%
- Ebitda 46.90%
- Net Worth 1.66%
- Total Assets 0.06%
About Span Generics
Span Generics Private Limited (SGPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 August 2009 and has a history of 15 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sandeep Ajmani, Deepti Ajmani, and Vinod Suri serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100DL2009PTC193604
-
Company No.
193604
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Aug 2009
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Span Generics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Ajmani
|
Director | 25-Jan-2023 | Current |
|
Deepti Ajmani
|
Director | 26-Aug-2009 | Current |
|
Vinod Suri
|
Director | 20-Feb-2022 | Current |
Financial Performance of Span Generics.
Span Generics Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 146.51% increase. The company also saw a substantial fall in profitability, with a 45.55% decrease in profit. The company's net worth moved up by a moderate rise of 1.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Span Generics?
In 2017, Span Generics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ecosol Industries Private LimitedSandeep Ajmani is a mutual person
-
Spangen Laboratories Private Limited
Deepti Ajmani and Vinod Suri are mutual person
-
Stride Exports Private Limited
Vinod Suri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Span Generics?
Unlock and access historical data on people associated with Span Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Span Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Span Generics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
